Receptor for advanced glycation end products (RAGE), a major extracellular binding target of S100P, has been associated with S100P-mediated cancer progression by triggering the oncogenic signaling pathway microRNA-155 and NF-κB in colon and pancreatic cancers, respectively [7, 8]. This evidence concerns the gene AGER and familial pancreatic carcinoma.